Comparative-Effectiveness

CEPAC Names New Members for 2015

OHE Publishes in the Journal of Comparative Effectiveness Research

Why is CER Taking So Long to Impact Healthcare Decision Making

PCORI Shown as a National Leader in CER

Why Must Oncologists Remain Wary of Non-Inferiority Trials?

National Pharmaceutical Council. 2014 Comparative Effectiveness Research and Environment Health Care Decision-Making Infographic.

NPCs Infographic On Comparative Effectiveness Research

How Do We Decide Which Drug Is Best?

Fifth Annual Survey On CER & Health Care Decision-Making

How Can Real World Data Be Used To Develop And Use Medicines?

Obamacare To Fund Hep C Comparative-Effectiveness Research

Biopharma Products Not ‘On Radar’ For Medicare Coverage Review

Are You Familiar With PCORI’s Principles Of Collaboration?

PCORI – What’s Next For Hepatitis C Research?

Early Access & Adaptive Licensing – Hot Topics At ISPOR Europe Annual Meeting

Why Is Observational CER Gaining Popularity In China?

Check Out The Newest THETA Rounds Lecture For A Brief History Of The Health Utilities Index

What Is Your Opinion On Informed Consent Rules In Comparison Studies – We Want To Know!

New Draft Guidelines Involving Risks In Comparative-Effectiveness Research – A Confusing Clarification

New Journal Targets Real-World Data, Health Outcomes, Healthcare Decision-Making & Big Data

How Do You Decide The Relevance And Credibility Of Observational Studies?

How Does Crossover Affect Overall Survival Analysis In Randomized Controlled Trials

Videos Promote Ethical Comparative-Effectiveness Research

AMCP’s Pre-Conference Comparative Effectiveness Research Certificate Program

The Politics Of Pharma Pricing: Are We Asking The Right Questions?

Are U.S. Cancer Patients Receiving Better Care Than Europeans?

Does PCORI Have The Capacity To Promote Significant Change?

Symposium On Innovation & Cost-Effectiveness Analysis

EBM – Time To Refresh And Redefine?

Will CER Really Deliver Better Patient Outcomes?

Categories

Stay Connected